Blueshift Asset Management LLC Buys Shares of 2,034 Teleflex Incorporated (NYSE:TFX)

Blueshift Asset Management LLC purchased a new position in shares of Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 2,034 shares of the medical technology company’s stock, valued at approximately $362,000.

Several other institutional investors have also modified their holdings of TFX. Avior Wealth Management LLC raised its holdings in Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after buying an additional 101 shares during the period. True Wealth Design LLC increased its position in shares of Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after acquiring an additional 166 shares in the last quarter. Banque Cantonale Vaudoise raised its holdings in shares of Teleflex by 184.8% during the third quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock worth $56,000 after acquiring an additional 146 shares during the period. IFP Advisors Inc lifted its position in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after acquiring an additional 217 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its stake in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after purchasing an additional 94 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE:TFX opened at $141.77 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a fifty day simple moving average of $163.17 and a 200 day simple moving average of $194.40. Teleflex Incorporated has a 1-year low of $128.55 and a 1-year high of $249.91. The stock has a market capitalization of $6.57 billion, a PE ratio of 28.19, a P/E/G ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.96%. Teleflex’s dividend payout ratio is 95.77%.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Piper Sandler restated a “neutral” rating and issued a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Raymond James cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Finally, Truist Financial reduced their target price on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a report on Monday, March 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.